Cargando…
Synthetic prodrug design enables biocatalytic activation in mice to elicit tumor growth suppression
Considering the intrinsic toxicities of transition metals, their incorporation into drug therapies must operate at minimal amounts while ensuring adequate catalytic activity within complex biological systems. As a way to address this issue, this study investigates the design of synthetic prodrugs th...
Autores principales: | Nasibullin, Igor, Smirnov, Ivan, Ahmadi, Peni, Vong, Kenward, Kurbangalieva, Almira, Tanaka, Katsunori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748823/ https://www.ncbi.nlm.nih.gov/pubmed/35013295 http://dx.doi.org/10.1038/s41467-021-27804-5 |
Ejemplares similares
-
Disrupting tumor onset and growth via selective cell tagging (SeCT) therapy
por: Vong, Kenward, et al.
Publicado: (2021) -
Homo- and Heterogeneous Glycoconjugates on the Basis of N-Glycans and Human Serum Albumin: Synthesis and Biological Evaluation
por: Kurbangalieva, Almira, et al.
Publicado: (2022) -
An artificial metalloenzyme biosensor can detect ethylene gas in fruits and Arabidopsis leaves
por: Vong, Kenward, et al.
Publicado: (2019) -
Targeted 1,3-dipolar cycloaddition with acrolein for cancer prodrug activation
por: Pradipta, Ambara R., et al.
Publicado: (2021) -
Unlocking the therapeutic potential of artificial metalloenzymes
por: TANAKA, Katsunori, et al.
Publicado: (2020)